Partners Group said it could cap capital withdrawals from more of its funds after a European gating sparked a private equity stock sell-off on Wednesday.
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.